SCHEMBL4915780

SCHEMBL4915780

C[C@H](Nc1cc(=O)c1=O)c1cccc(O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 5/20 0.54
ADRB1 P08588 2/20 0.42
ADRA1A P35348 2/20 0.42
MIF P14174 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2B P41595 1/20 0.42
HIF1A Q16665 4/20 0.41
ADRB2 P07550 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
ADRB3 P13945 1/20 0.41
TSHR P16473 1/20 0.41
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41
NFKB1 P19838 1/20 0.41
DRD1 P21728 1/20 0.41
HTR7 P34969 1/20 0.41
ADRA1B P35368 1/20 0.41
DRD3 P35462 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4927735 1.00 MAPKAPK2 (0.54) MAPKAPK2ADRB1ADRA1AMIFHTR2A
SCHEMBL4926004 0.79 CASR (0.49) MAPKAPK2ALDH1A1CYP3A4HTTSMN1; SMN2
SCHEMBL6176448 0.73 LMNA (0.50) MAPKAPK2ADRB1ADRA1AMIFHTR2A
SCHEMBL6176429 0.73 LMNA (0.50) MAPKAPK2ADRB1ADRA1AMIFHTR2A
SCHEMBL2808694 0.73 LMNA (0.50) MAPKAPK2ADRB1ADRA1AMIFHTR2A
SCHEMBL414424 0.72 HIF1A (0.55) MAPKAPK2ADRB1ADRA1AMIFHTR2A
SCHEMBL10305659 0.72 HIF1A (0.55) MAPKAPK2ADRB1ADRA1AMIFHTR2A
SCHEMBL410935 0.72 HIF1A (0.55) MAPKAPK2ADRB1ADRA1AMIFHTR2A
SCHEMBL27992460 0.72 HIF1A (0.55) MAPKAPK2ADRB1ADRA1AMIFHTR2A
SCHEMBL4366319 0.71 MAPKAPK2 (1.00) MAPKAPK2CYP3A4CYP2C9PDGFRAPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312244-A1 Squaric Acid Derivatives as Protein Kinase Inhibitors MERCK PATENT GMBH (DE) 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312244-A1 Squaric Acid Derivatives as Protein Kinase Inhibitors CHEK1, CHEK2, SIK1 MAPKAPK2 377/4885ADRB1 4066/4885ADRA1A 3742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.